Solventum Corporation
SOLV | NYSE
$88.84
$0 (0.00%)
At close: Sep 21, 2026, 4:00 PM ET
$88.50
-$0.34 (-0.38%)
Pre-market:
Sep 22, 2026, 4:47 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 8.33B | 8.25B | 8.2B | 8.13B | 8.17B | 7.28B |
Cost of Revenue | 3.87B | 3.66B | 3.5B | 3.44B | 3.25B | 2.97B |
Gross Profit | 4.45B | 4.59B | 4.69B | 4.7B | 4.92B | 4.32B |
Operating Income | 2.18B | 1.04B | 1.69B | 1.69B | 1.88B | 1.43B |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 1.71B | 605M | 1.67B | 1.69B | 1.88B | 1.44B |
Net Income | 1.56B | 479M | 1.35B | 1.34B | 1.46B | 1.14B |
Selling & General & Admin | 3.08B | 2.78B | 2.24B | 2.24B | 2.28B | 2.17B |
Research & Development | 739M | 775M | 758M | 767M | 766M | 719M |
Other Expenses | -1.55B | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 2.27B | 3.56B | 3B | 3B | 3.04B | 2.89B |
Interest Expense | 347M | 367M | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 6.14B | 7.22B | 6.51B | 6.44B | 6.29B | 5.85B |
Income Tax Expense | 157M | 127M | 321M | 349M | 422M | 302M |
Shares Outstanding (Basic) | 174.1M | 173.2M | 172.71M | 172.47M | 172.47M | 172.47M |
Shares Outstanding (Diluted) | 175.3M | 173.7M | 172.71M | 172.47M | 172.47M | 172.47M |
EPS (Basic) | 8.94 | 2.77 | 7.79 | 7.79 | 8.47 | 6.60 |
EPS (Diluted) | 8.88 | 2.76 | 7.79 | 7.79 | 8.47 | 6.60 |
EBITDA | 2.55B | 1.53B | 2.23B | 2.27B | 2.48B | 2.03B |
EBIT | 2.06B | 972M | 1.67B | 1.69B | 1.88B | 1.43B |
Depreciation & Amortization | 489M | 555M | 561M | 578M | 597M | 599M |
Add to Watchlist
Select watchlists to add or remove SOLV